ARN25068
ARN25068 is a sub-micromolar inhibitor of the three protein kinases, GSK-3β, FYN and DYRK1A to tackle tau hyperphosphorylation[1].
Product Specifications
CAS Number
[2649882-80-2]
UNSPSC
12352005
Target
DYRK; GSK-3
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/arn25068.html
Purity
99.66
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
C1(CNC2=NC(NC3=CC(C4CC4)=NN3)=C5SC=CC5=N2)=CC=CC=C1
Molecular Formula
C19H18N6S
Molecular Weight
362.45
References & Citations
[1]Stefania Demuro, et al. ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders. Eur J Med Chem. 2022 Feb 5;229:114054.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DYRK1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1133257-01 0.02 mg (E-Coli)
Recombinant Vaccinia virus Serine proteinase inhibitor 2 (SPI-2)
Ask
View Details MBS1133257-02 0.02 mg (Yeast)
Recombinant Vaccinia virus Serine proteinase inhibitor 2 (SPI-2)
Ask
View Details 
MBS1133257-03 0.1 mg (E-Coli)
Recombinant Vaccinia virus Serine proteinase inhibitor 2 (SPI-2)
Ask
View Details 
MBS1133257-04 0.1 mg (Yeast)
Recombinant Vaccinia virus Serine proteinase inhibitor 2 (SPI-2)
Ask
View Details 
MBS1133257-05 0.02 mg (Baculovirus)
Recombinant Vaccinia virus Serine proteinase inhibitor 2 (SPI-2)
Ask
View Details MBS1133257-06 0.02 mg (Mammalian-Cell)
Recombinant Vaccinia virus Serine proteinase inhibitor 2 (SPI-2)
Ask
View Details